AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05307536 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Autologous BMMNCs transplantation and educational intervention
Description: Biological/ Vaccine: Autologous bone marrow-derived mononuclear cell infusion (BM-MNCs) will be administrated at baseline, and the second infusion will be performed six months after the first administration. For each transplantation, the bone marrow will be harvested through an anterior iliac crest puncture under general anesthesia in the operating theatre. The volume collected depends on the patient's body weight based on our experience from a previous study as follows: 8 ml/kg for patients under 10 kg; \[80 ml + (body weight in kg - 10) x 7 ml\] for patients above 10 kg but no more than 250 ml in total.~Educational intervention: 6 months based on the Early Start Denver Model
Study NCT05464472 — intervention group
Intervention type: DEVICE
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Description: Guideline/ FDA approved implantation of a Transcatheter Aortic Valve Implantation (TAVI)
Study NCT05840978 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics
Description: Oral capsules
Study NCT05840978 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral capsules
Study NCT05569564 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ridge splitting followed by ossedensificaion
Description: Ridge splitting followed by ossedensificaion with osseodensifying burs.
Study NCT04762082 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tadalafil 10 MG
Description: comparison of tadalafil gummy 10mg and tadalafil oral tablet 10mg
Study NCT04762082 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tadalafil 10 MG
Description: comparison of tadalafil gummy 10mg and tadalafil oral tablet 10mg
Study NCT05307536 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Educational intervention
Description: Educational intervention: 6 months based on the Early Start Denver Model
Study NCT05569564 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Osseodensification
Description: Pilot drill is used to make the initial osteotomy to the desired depth, then osseodensifying burs will be used in sequence, gradually wider diameter in a counterclockwise rotation and bouncing motion under profuse saline irrigation
Study NCT05569564 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Osseodensification
Description: Pilot drill is used to make the initial osteotomy to the desired depth, then osseodensifying burs will be used in sequence, gradually wider diameter in a counterclockwise rotation and bouncing motion under profuse saline irrigation
Study NCT05904353 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ambulant nurse-assisted administration of zoledronic acid
Description: Patients from the intervention regions will be followed by the protocol of ambulant nurse-assisted administration of zoledronic acid.
Study NCT05904353 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: General practitioners are requested to take care of the follow-up, through the patients and the discharge summary, with annual infusions of zoledronic acid.
Study NCT06266845 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: In-person Escape Room
Description: The in-person escape room will be conducted in the nursing laboratory of a Higher Education Institution (HEI), equipped with a high-fidelity mannequin to simulate a critical patient and create a realistic environment. Participants will be divided into groups, with one group entering at a time as requested. During the in-person escape room, participants will interact with the patient mannequin, hospital equipment and devices, as well as with objects and clues in the environment. The game duration will be 30 minutes to ensure equal conditions among participants and prevent time distortions. Interactions and participants' performance will be recorded by the facilitator, guiding the feedback.
Study NCT06266845 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Virtual Escape-Room
Description: The virtual escape room will be conducted in a classroom of an HEI, utilizing an online platform that allows the virtual reproduction of the game. Each group will have access to a tablet or computer to participate in the game provided by the researcher. During the game, participants will interact with the platform interface and solve challenges to escape the virtual room within 30 minutes. Thus, each group will have a maximum of 30 minutes to complete the escape room, ensuring equal conditions among participants. Records of interactions and participant performance will be logged for later analysis and feedback.
Study NCT05240170 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RIRS
Description: The standard RIRS will be performed using a disposable flexible ureteroscope. Holmium: YAG laser will be used for stone dusting and fragmentation. If indicated, JJ ureteral stent will be placed at the end of the procedure.
Study NCT05240170 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SWL
Description: Patients who underwent SWL at our institution in the past five years. According to (a) the type of renal anomaly (rotation, position, or rotation/position anomaly), (b) the size of the stone (±5 mm), (c) location of the stone (lower polar or non-lower polar), and (d) density of the stone (>800 HU or ≤800 HU), matched cases will be selected for comparison.
Study NCT04801797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Intravenous infusion
Study NCT04801797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idarubicin
Description: Intravenous infusion
Study NCT04735315 — intervention group
Intervention type: OTHER
Intervention: Preterm birth
Description: The study compares young adult subjects born premature (\< 29 weeks) versus term > 37-41 weeks)
Study NCT05412043 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance therapy
Description: The dance group will attend choreo-based dance therapy which includes both cognitive training to remember the choreo's and motor training to execute them (with and without music). Each session will consist of a ten-minute warm up, dance training and a ten-minute cool down. The participants will be taught three choreographies, which will increase in difficulty level. 1) floor work on a slow rhythm with focus on proprioception, abdominal muscle strength, coordination and working memory. 2) slow paced with a group part and a canon part with focus on working memory, static and dynamic balance and strength. Furthermore, it will require dynamic balance, walking and cognition. 3) higher rhythm and will be danced with a cane which will require more speed, coordination and dual tasking.
Study NCT05412043 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Psychometric properties (Validity, Reliability) of interlimb coordination- and cognitive-fatigability
Description: The study consists of 2 test sessions, separated by 5-7 days of interval. The sessions 1 and 2 will be composed of cognitive test battery, questionnaires to be filled, information about the use of actigraph, clinical outcomes and interlimb coordination tests
Study NCT05412043 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychometric properties (Validity, Reliability) of interlimb coordination- and cognitive-fatigability
Description: The study consists of 2 test sessions, separated by 5-7 days of interval. The sessions 1 and 2 will be composed of cognitive test battery, questionnaires to be filled, information about the use of actigraph, clinical outcomes and interlimb coordination tests
Study NCT05412043 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Psychometric properties (Validity, Reliability) of interlimb coordination- and cognitive-fatigability
Description: The study consists of 2 test sessions, separated by 5-7 days of interval. The sessions 1 and 2 will be composed of cognitive test battery, questionnaires to be filled, information about the use of actigraph, clinical outcomes and interlimb coordination tests
Study NCT06512610 — intervention group
Intervention type: OTHER
Intervention: Middle Eastern or North Coast of Africa patients with newly AML
Description: Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia in MENAFC patients
Study NCT04801797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daunorubicin
Description: Intravenous infusion
Study NCT04801797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal daunorubicin and cytarabine
Description: Intravenous infusion
Study NCT05309681 — intervention group
Intervention type: OTHER
Intervention: Epworth's sleepiness scale; unstimulated saliva sample
Description: Unstimulated saliva sample; Epworth's sleepiness scale
Study NCT05844202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alveavax-v1.2
Description: BA.2/Omicron optimized plasmid DNA vaccine for the prevention of COVID-19
Study NCT05844202 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Janssen Ad26.COV2.S
Description: COVID-19 vaccine by Janssen / Johnson \& Johnson
Study NCT05679349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Complete survey
Study NCT05679349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Activity
Description: Undergo online shared decision making training and distance learning
Study NCT05679349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Complete survey
Study NCT05679349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Undergo electronic health record review
Study NCT05679349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Counseling
Description: Undergo shared decision making counseling
Study NCT05679349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Electronic Health Record Review
Description: Undergo electronic health record review
Study NCT04801797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Orally by mouth
Study NCT04801797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Intravenous infusion
Study NCT04787211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BRII-196 and BRII-198
Description: BRII-196 and BRII-198 given by intravenous administration
Study NCT04787211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo given by intravenous administration
Study NCT06271928 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yijing Keli
Description: Once enrolled, participants will be administrated Yijing Keli
Study NCT06006910 — intervention group
Intervention type: BEHAVIORAL
Intervention: Column-based nudge in the EHR
Description: The nudge is a column in EPIC that flags patients coming to the clinic as a new visit with documented ER+ breast cancer. The nudge flag can pop up when hovered over to remind surgeons of the Choosing Wisely criteria and to consider omission of SLNB.
Study NCT06307249 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: SNP
Description: Diagnostics of patients' carriers or not of the risk allele(s)
Study NCT06006910 — intervention group
Intervention type: BEHAVIORAL
Intervention: No column-based nudge in the EHR
Description: No intervention control period prior to nudge deployment.
Study NCT06054503 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: prototype of sensor
Description: The investigational device is composed of a sensor placed on the respiratory line of the ventilated patients and connected to a ventilation measure unit which records the ventilation parameters
Study NCT06307249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib 125mg
Description: Palbociclib 125mg/day/os over 21 days every 28 days
Study NCT06307249 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 10mg/kg every 21 days
Study NCT06054503 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: prototype of sensor
Description: The investigational device is composed of a sensor placed on the respiratory line of the ventilated patients and connected to a ventilation measure unit which records the ventilation parameters
Study NCT04913441 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine physical therapy
Description: Patients in this group will get every session routine physical therapy of 30 minutes 3 times per week on alternative days for 12 weeks
Study NCT04913441 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual physical therapy with routine physical therapy
Description: Patients in this group will get every session Manual physical therapy with routine physical therapy of 40 to 45 minutes 3 times per week on alternative days for 12 weeks
Study NCT04913441 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching physical therapy with routine physical therapy
Description: Patients in this group will get every session of Stretching physical therapy with routine physical therapy of 40 to 45 minutes 3 times per week on alternative days for 12 weeks
Study NCT05144828 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intercostal Nerve Cryoablation
Description: Patients will receive intraoperative intercostal nerve cryoablation using CryoICE® CRYOS-L cryoablation probes (AtriCure, Inc) to intercostal spaces 4th to 10th in thoracoabdominal aortic repairs and 4th to 8th in descending thoracic aortic repair cases prior to wound closure.
Study NCT05144828 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA)
Description: Patients will have access to the standard PCA (patient-controlled analgesia) offered at Froedtert Hospital. This includes tylenol 650 mg oral, robaxin 500 mg oral, and tramadol 25-50 mg oral. All patients will have the first two ports placed at which time an intercostal nerve block of nerves 4-9 will be performed using 0.5% Marcaine with Epinephrine.
Study NCT05144828 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Patient-controlled analgesia (PCA)
Description: Patients will have access to the standard PCA (patient-controlled analgesia) offered at Froedtert Hospital. This includes tylenol 650 mg oral, robaxin 500 mg oral, and tramadol 25-50 mg oral. All patients will have the first two ports placed at which time an intercostal nerve block of nerves 4-9 will be performed using 0.5% Marcaine with Epinephrine.
Study NCT04834726 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Opt-In (Call-Back)
Description: Messaging will include a prompt to agree to scheduling. If patient agrees, the access center will call these patients back to schedule, calling up to 3 times.
Study NCT04834726 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Opt-in (In-Bound)
Description: Messaging will include a prompt to agree to scheduling followed by a prompt to call the Penn Medicine Vaccine Scheduling Hotline to schedule their vaccine appointment.
Study NCT04834726 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Message
Description: The message describes that the patient is eligible for the COVID vaccine.
Study NCT04834726 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinician Endorsement
Description: The message will describe an endorsement from the provider to get the vaccination.
Study NCT04834726 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scarcity
Description: The message will highlight the limited availability and the elevated priority for the patient to receive the vaccine at Penn Medicine.
Study NCT04834726 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Opt-Out Framing
Description: This will highlight that a vaccine is reserved for the patient, implying that they need to opt-out.
Study NCT04834726 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Phone Call
Description: The access center will call these patients to schedule their vaccine appointment. These patients will not receive text messaging.
Study NCT05719662 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Weight bearing exercises
Description: Weight bearing exercises
Study NCT05719662 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Jaffrey's core stability exercises
Description: Jaffrey's core stability exercises
Study NCT05893576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS9531
Description: Receive a single dose of HRS9531 of original formulation.
Study NCT05893576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS9531
Description: Receive a single dose of HRS9531 of new formulation.
Study NCT05947045 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive training via iPad
Description: Participants will complete five sessions of the Cogmed training program on an iPad. Participants will complete sessions over the course of one to two weeks while on campus for radiotherapy. Each session will take place in the Psychology Clinic and consist of 15 to 20 minutes of Cogmed training.
Study NCT05947045 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive training via virtual reality
Description: Participants will complete five sessions of the Cogmed training program within virtual reality. Participants will complete sessions over the course of one to two weeks while on campus for radiotherapy. Each session will take place in the Psychology Clinic and consist of 15 to 20 minutes of Cogmed training.
Study NCT05193370 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Description: Angiotensin II (Giapreza) is a pharmacologic version of a naturally occurring hormone of the same name, peptide hormone of the renin-angiotensin-aldosterone system (RAAS), that was FDA-approved in 2017 as a vasoconstrictive agent in the treatment of vasodilatory shock.
Study NCT05162638 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: thoracic duct cannulation
Description: Contrast is injected into lymph nodes until lymphatics visualized at about level of L3 lumbar spine. After target lymphatic vessel is identified, needle is passed transabdominally into the vessel. Guidewire is advanced through the needle into the lymph vessel \& advanced into thoracic duct. Microcatheter is then advanced into thoracic duct over the wire.~IN \& OUT-up to 100mL collected via catheter over 30-min at 2 levels within thoracic duct, then catheter removed.~INDWELLING-As described above, then guidewire placed through original catheter \& advanced into subclavian vein. Vascular sheath is placed into vein in the upper arm under ultrasound/fluoroscopy guidance. Wire in the subclavian vein then snared through venous access sheath \& pulled out. Catheter then threaded \& advanced over the wire until tip is in thoracic duct. Catheter from thoracic duct removed, leaving catheter extending from arm into thoracic duct. Catheter left in place up to 21 days for sampling.
Study NCT05193370 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vasopressin
Description: Vasopressin (Vasostrict) is a pharmacologic version of a naturally occurring peptide hormone that serves as a vasoconstrictive agent in the treatment of vasodilatory shock.
Study NCT04493957 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACCOMPAGNE Education Program
Description: The following workshops will be organised :~* Presentation workshop~* Cognitive skills workshop~* Perception and Environment workshop~* Responsibilities workshop~* Representation workshop -~* Caregivers workshop,~* Solutions workshop
Study NCT04493957 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usuals recommandations
Description: Recommendations consist of a description of the cognitive and sensorimotor risk factors specific to the patient for driving and advice for the adaptation of driving or the recommendation of the stopping of driving. It is usually served by oral or written to the patient, with mention in the patient's file of the recommendation and issued in the presence of his close companion.
Study NCT06525038 — intervention group
Intervention type: OTHER
Intervention: All groups were observed for clinical end-points described in the study protocol
Description: All groups were observed for clinical end-points (mortality, readmission to emergency service) described in the study protocol.
Study NCT04968964 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DiviTum® TKa assay
Description: -Determines serum enzymatic activity of TK1
Study NCT04968964 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Study Care Plans
Description: -Study Care Plans will be completed prior to and post release of serum DiviTum® TKa value
Study NCT06068296 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: short term memory assessment
Description: Aphasia group: The Dutch verbal STM assessment tool will be administered over a time span of maximum two consecutive days depending on how fatigued the patient is during testing.~Healthy control group: the Dutch verbal STM assessment tool will be administered.
Study NCT06068296 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Oxford cognitive screen
Description: Evaluation of the cognitive abilities of the patients with aphasia.
Study NCT06068296 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Token Test
Description: Evaluation of the severity of the aphasia in patients with aphasia.
Study NCT06068296 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Montreal cognitive assessment
Description: Evaluation of cognitive dysfunction in the group of healthy volunteers.